Taking your startup to the United States
The Melbourne Accelerator Program and U.S. Consulate General Melbourne have teamed up to bring you an exciting panel discussion exploring the highs and lows of what it takes to grow an Australian business in the U.S.
The panel will draw insight from the recent launch of ’37 Degrees Latitude’, a new podcast series hosted by Consul General Michael F. Kleine.
Along with Wei Sue of Navi Medical Technologies, our panel is rounded out by Rachael Neumann of Working Theory Angels, a US citizen and highly experienced founder and investor passionate about helping companies scale and increase their impact and hosted by Professor Colin McLeod, Director of the Melbourne Entrepreneurial Centre.
What is ’37 Degrees Latitude’?
If geography is destiny, there must be something special about 37 degrees latitude. At 37˚S, you’ll find Melbourne, Australia; at 37˚N, you’ll find Silicon Valley.
The podcast series follows major Australian startups like Culture Amp, Smileyscope, Blackbird Ventures and 99 Designs share their insights on how they made it big in the U.S.
Hosted by Mike Kleine, the U.S. Consul General to Melbourne, the series explores what it takes to grow an Australian business in the U.S; Australia’s most important economic partner with a two-way trade partnership worth more than $80 billion dollars annually.
What is the Melbourne Accelerator Program (MAP)?
As one of the first University Accelerators in Australia, The Melbourne Accelerator Program is helping to create truly global startups, with many of their outstanding alumni including some of Australia’s most successful startups.
MAP alumni have featured prominently in the Australian and international entrepreneurial ecosystem. Smiley Scope recently shared their experience on the ’37 Degree Latitude’ podcast and at this event Navi Medical Technologies will share their fascinating path to US expansion.
Having had a remarkable 2020, Navi Medical Technologies raised over $1M in grant funding including USD$50,000 for the NCC-PDI Pediatric Innovation Grant (US FDA) and $396,000 for the Accelerating Commercialisation Grant (Department of Industry, Innovation and Science).